Medications ›methdilazine

methdilazine

RxCUI 29648 ingredient

Contraindicated with · 24

Diagnoses10

Jaundice Hyperbilirubinemia Coma Infant, Newborn Lactation Postpartum Period Unconsciousness Infant Age Groups Drug Hypersensitivity

Condition families14

Consciousness Disorders Bone Marrow Diseases Neurobehavioral Manifestations Skin Manifestations Hematologic Diseases Reproductive Physiological Phenomena Hemic and Lymphatic Diseases Neurologic Manifestations Nervous System Diseases Signs and Symptoms Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 27

Diagnoses20

Pityriasis Rosea Dermatitis, Allergic Contact Pityriasis Eczema Dermatitis, Contact Hypersensitivity, Delayed Dermatitis, Atopic Skin Diseases, Genetic Skin Diseases, Eczematous Urticaria Skin Diseases, Papulosquamous Rhinitis, Allergic, Perennial Rhinitis, Allergic Dermatitis Skin Diseases, Vascular Rhinitis Respiratory Hypersensitivity Genetic Diseases, Inborn Hypersensitivity, Immediate Hypersensitivity

Condition families7

Nose Diseases Otorhinolaryngologic Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Skin Diseases Respiratory Tract Diseases Skin and Connective Tissue Diseases Immune System Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.